Lessee, Operating Lease, Liability, to be Paid, Year Three of Monopar Therapeutics from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Monopar Therapeutics quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD history and change rate from 31 Mar 2022 to 30 Sep 2025.
  • Monopar Therapeutics Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 30 Sep 2025 was $10,740.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)

Monopar Therapeutics Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $10,740 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $10,740 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q3 2022 $8,476 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $8,476 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $4,758 31 Mar 2022 10-Q 12 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.